Director, Sterile & Specialty Products
Merck & Co., Inc.
Rahway, New Jersey
Stephanie E. Barrett, PhD., is a Senior Principal Scientist and is one of Merck’s leading experts in polymer and bioconjugate chemistry for enabled delivery of small molecule and macromolecular drugs, having made influential contributions to the discovery of novel polymer conjugates for siRNA therapeutics, polymer excipients for oral dosage forms, and polymer-based long-acting injectables (LAI) and implantables. She is currently leading the team responsible for the design of Merck’s next generation of long-acting implant and injectable products—with potential applications in Neuroscience, HIV and other infectious diseases. For her technical and leadership achievements, she was recognized by Business Insider as one of the top 30 under 40 biopharma leaders shaping the future of medicine.
Stephanie was recently elected to the Board of Directors of CRS. She also serves as the Co-Chair of the LAI working group, which is part of the International Consortium for Innovation and Quality in Pharmaceutical Development. In this role, she is leading a team aimed at increasing awareness around the development of LAI products and looking for ways to accelerate these new medicines for patients. Stephanie actively participates in external forums advocating the professional development of women in science and co-leads the internal DEI team.
Disclosure information not submitted.
Monday, October 17, 2022
12:00 PM – 1:00 PM ET
Tuesday, October 18, 2022
4:10 PM – 4:30 PM ET
Wednesday, October 19, 2022
11:30 AM – 12:30 PM ET